SMARCB1/INI1-deficient tumors of adulthood [version 2; peer review: 2 approved]
The SMARCB1/INI1 gene was first discovered in the mid-1990s, and since then it has been revealed that loss of function mutations in this gene result in aggressive rhabdoid tumors. Recently, the term “rhabdoid tumor” has become synonymous with decreased SMARCB1/INI1 expression. When genetic aberratio...
Main Authors: | Nathaniel A. Parker, Ammar Al-Obaidi, Jeremy M. Deutsch |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-12-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-662/v2 |
Similar Items
-
SMARCB1 (INI-1) DEFICIENT POORLY DIFFERENTIATED CARCINOMA OF SINONASAL TRACT
by: Usman Hassan, et al.
Published: (2016-08-01) -
SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis
by: Bourdon Violaine, et al.
Published: (2011-01-01) -
The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report
by: Kazushi Yoshida, et al.
Published: (2018-04-01) -
SMARCB1 (INI1)-deficient sinonasal carcinoma, basaloid subtype: First reported case in Taiwan and literature review
by: Chen-Pu Ou, et al.
Published: (2020-11-01) -
Malignant rhabdoid tumor of the kidney in an adult with loss of INI1 expression and mutation in the SMARCB1 gene
by: Eunkyung Han, et al.
Published: (2021-03-01)